Periostin: A downstream mediator of ephb4-induced osteogenic differentiation of human bone marrow-derived mesenchymal stem cells

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Zhang, Fei ^a   Zhang, Zehua ^a   Sun, Dong ^a   Dong, Shiwu ^a   Xu, Jianzhong ^a   Dai, Fei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COLLAGEN TYPE 1; EPHRIN B2; EPHRIN RECEPTOR B4; GLYCOGEN SYNTHASE KINASE 3BETA; SERINE; TRANSCRIPTION FACTOR RUNX2; VITRONECTIN RECEPTOR; WNT PROTEIN;

ARTICLE; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84953849537     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/7241829     Document Type: Article

References (42)

1. C. Zhao, N. Irie, Y. Takada et al. , "Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis, " Cell Metabolism, vol. 4, no. 2, pp. 111-121, 2006.
2. F. M. Takyar, S. Tonna, P. W. M. Ho et al. , "EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone, " Journal of Bone andMineral Research, vol. 28, no. 4, pp. 912-925, 2013.
3. K. Matsuo and N. Irie, "Osteoclast-osteoblast communication, " Archives of Biochemistry and Biophysics, vol. 473, no. 2, pp. 201-209, 2008.
4. J. Ivaska and J. Heino, "Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix, " Cellular and Molecular Life Sciences, vol. 57, no. 1, pp. 16-24, 2000.
5. K. Anselme, "Osteoblast adhesion on biomaterials, " Biomaterials, vol. 21, no. 7, pp. 667-681, 2000.
6. B. Merle and P. Garnero, "The multiple facets of periostin in bone metabolism, " Osteoporosis International , vol. 23, no. 4, pp. 1199-1212, 2012.
7. N. Bonnet, S. J. Conway, and S. L. Ferrari, "Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 37, pp. 15048-15053, 2012.
8. K. Horiuchi, N. Amizuka, S. Takeshita et al. , "Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor β, " Journal of Bone and Mineral Research, vol. 14, no. 7, pp. 1239-1249, 1999.
9. W. Wen, E. Chau, L. Jackson-Boeters, C. Elliott, T. D. Daley, and D. W. Hamilton, "TGF-β1 and FAK regulate periostin expression in PDL fibroblasts, " Journal of Dental Research, vol. 89, no. 12, pp. 1439-1443, 2010.
10. K. Inai, R. A. Norris, S. Hoffman, R. R. Markwald, and Y. Sugi, "BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis, " Developmental Biology, vol. 315, no. 2, pp. 383-396, 2008.
11. N. Jaiswal, S. E. Haynesworth, A. I. Caplan, and S. P. Bruder, "Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro, " Journal of Cellular Biochemistry, vol. 64, no. 2, pp. 295-312, 1997.
12. F. Zhang, Z. Zhang, D. Sun, S. W. Dong, J. Xu, and F. Dai, "EphB4 promotes osteogenesis of CTLA4-modified bone marrow-derived mesenchymal stem cells through cross talk with Wnt pathway in xenotransplantation, " Tissue Engineering Part A, vol. 21, no. 17-18, pp. 2404-2416, 2015.
13. A. Pennisi, W. Ling, X. Li et al. , "The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth, " Blood, vol. 114, no. 9, pp. 1803-1812, 2009.
14. M. Brunner, P. Jurdic, J. P. Tuckerman, M. R. Block, and D. Bouvard, "New insights into adhesion signaling in bone formation, " International Review of Cell and Molecular Biology, vol. 305, pp. 1-68, 2013.
15. L. A. Hidalgo-Bastida and S. H. Cartmell, "Mesenchymal stem cells, osteoblasts and extracellular matrix proteins: enhancing cell adhesion and differentiation for bone tissue engineering, " Tissue Engineering-Part B: Reviews, vol. 16, no. 4, pp. 405-412, 2010.
16. N. Datta, H. L. Holtorf, V. I. Sikavitsas, J. A. Jansen, and A. G. Mikos, "Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation ofmarrowstromal cells, " Biomaterials, vol. 26, no. 9, pp. 971-977, 2005.
17. C. H. Damsky, "Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling, " Bone, vol. 25, no. 1, pp. 95-96, 1999.
18. C. Galli, M. Piergianni, M. Piemontese et al. , "Periostin improves cell adhesion to implantable biomaterials and osteoblastic differentiation on implant titanium surfaces in a topography-dependent fashion, " Journal of Biomedical Materials Research-Part A, vol. 102, no. 11, pp. 3855-3861, 2013.
19. J. L. Su, J. Chiou, C. H. Tang et al. , "CYR61 regulates BMP-2-dependent osteoblast differentiation through the alphavbeta3 integrin/integrin-linked kinase/ERK pathway, " The Journal of Biological Chemistry, vol. 285, no. 41, pp. 31325-31336, 2010.
20. Y. S. Park, S. Hwang, Y. M. Jin et al. , "CCN1 secreted by tonsil-derived mesenchymal stem cells promotes endothelial cell angiogenesis via integrin αvβ3 and AMPK, " Journal of Cellular Physiology, vol. 230, no. 1, pp. 140-149, 2015.
21. M. Gerbaix, L. Vico, S. L. Ferrari, and N. Bonnet, "Periostin expression contributes to cortical bone loss during unloading, " Bone, vol. 71, pp. 94-100, 2015.
22. N. Bonnet, E. Gineyts, P. Ammann, S. J. Conway, P. Garnero, and S. Ferrari, "Periostin deficiency increases bone damage and impairs injury response to fatigue loading in adult mice, " PLoS ONE, vol. 8, no. 10, Article IDe78347, 2013.
23. S. C. Heo, W. C. Shin, M. J. Lee et al. , "Periostin accelerates bone healing mediated by human mesenchymal stem cell-embedded hydroxyapatite/tricalcium phosphate scaffold, " PLOS ONE, vol. 10, no. 3, Article ID e0116698, 2015.
24. A. Oshima, H. Tanabe, T. Yan, G. N. Lowe, C. A. Glackin, and A. Kudo, "A novel mechanism for the regulation of osteoblast differentiation: transcription of periostin, a member of the fasciclin I family, is regulated by the bHLH transcription factor, Twist, " Journal of Cellular Biochemistry, vol. 86, no. 4, pp. 792-804, 2002.
25. J. Litvin, A.-H. Selim, M. O. Montgomery et al. , "Expression and function of periostin-isoforms in bone, " Journal of Cellular Biochemistry, vol. 92, no. 5, pp. 1044-1061, 2004.
26. I. Mertens-Walker, B. C. Fernandini, M. S. Maharaj et al. , "The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of Integrin-β8 in prostate cancer cells, "BMC Cancer, vol. 15, article 164, 2015.
27. M. Li, J. Zhao, J. Qiao, C. Song, and Z. Zhao, "EphB4 regulates the growth and migration of pancreatic cancer cells, " Tumor Biology, vol. 35, no. 7, pp. 6855-6859, 2014.
28. B. D. Ferguson, R. Liu, C. E. Rolle et al. , "The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target, " PLoS ONE, vol. 8, no. 7, Article ID e67668, 2013.
29. M. G. Coulthard, M. Morgan, T. M. Woodruff et al. , "Eph/ ephrin signaling in injury and inflammation, " The American Journal of Pathology, vol. 181, no. 5, pp. 1493-1503, 2012.
30. J. P. Himanen, "Ectodomain structures of Eph receptors, " Seminars in Cell and Developmental Biology, vol. 23, no. 1, pp. 35-42, 2012.
31. P. W. Janes, E. Nievergall, and M. Lackmann, "Concepts and consequences of Eph receptor clustering, " Seminars in Cell and Developmental Biology, vol. 23, no. 1, pp. 43-50, 2012.
32. T. J. Martin, E. H. Allan, P. W. M. Ho et al. , "Communication between ephrinB2 and EphB4 within the osteoblast lineage, " in Osteoimmunology, vol. 658, pp. 51-60, Springer, 2009.
33. S. Tonna, F. M. Takyar, C. Vrahnas et al. , "EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis, " The FASEB Journal, vol. 28, no. 10, pp. 4482-4496, 2014.
34. E. G. Tierney, K. McSorley, C. L. Hastings et al. , "High levels of ephrinB2 over-expression increases the osteogenic differentiation of humanmesenchymal stem cells and promotes enhanced cell mediated mineralisation in a polyethyleneimine-ephrinB2 gene-activated matrix, " Journal of Controlled Release, vol. 165, no. 3, pp. 173-182, 2013.
35. E. H. Allan, K. D. Hausler, T. Wei et al. , "EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts, " Journal of Bone andMineral Research, vol. 23, no. 8, pp. 1170-1181, 2008.
36. T. F. Day, X. Guo, L. Garrett-Beal, and Y. Yang, "Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis, " Developmental Cell, vol. 8, no. 5, pp. 739-750, 2005.
37. T. P. Hill, D. Spater, M. M. Taketo, W. Birchmeier, and C. Hartmann, "Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes, " Developmental Cell, vol. 8, no. 5, pp. 727-738, 2005.
38. J. A. Kennell and O. A. MacDougald, "Wnt signaling inhibits adipogenesis through β-catenin-dependent and -independent mechanisms, " Journal of Biological Chemistry, vol. 280, no. 25, pp. 24004-24010, 2005.
39. R. Baron and G. Rawadi, "Minireview: targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton, " Endocrinology, vol. 148, no. 6, pp. 2635-2643, 2007.
40. A. J. Harwood, "Regulation ofGSK-3: a cellularmultiprocessor, " Cell, vol. 105, no. 7, pp. 821-824, 2001.
41. R. Baron and M. Kneissel, "WNTsignaling in bone homeostasis and disease: from human mutations to treatments, " Nature Medicine, vol. 19, no. 2, pp. 179-192, 2013.
42. G. Martiny-Baron, P. Holzer, E. Billy et al. , "The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis, " Angiogenesis, vol. 13, no. 3, pp. 259-267, 2010.